FIG 4.
Nasopharyngeal viral loads over time in the placebo (n = 5) and XAV-19 2-mg/kg (n = 4) groups. The evolution of median viral loads over time is shown. D1, day 1; LOD, limit of detection (2.2 log10 copies/ml); 0, no signal detected.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.